MGRX Other Disclosure
Cohen Jacob D. · SEC Form 4 · Filed Oct 6, 2026
Other
Reported value range
Not reported
Cohen Jacob D. Chief Executive Officer
MGRX
Mangoceuticals, Inc.
MGRX
Transaction date
Dec 19, 2025
Public filing date
Oct 6, 2026
Filing lag
Filed 291 days later
MGRX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Convertible Promissory Note on Common Stock
- Quantity / price
- Derivative security
- SEC ownership
- Direct
- Transaction code
- J
- Form
- 4
- Filing identifier
- 0001493152-26-045858
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Mangoceuticals, Inc. MGRX | Gift | Aug 11, 2026 | $0 |
| Mangoceuticals, Inc. MGRX | Gift | Aug 11, 2026 | $0 |
| Mangoceuticals, Inc. MGRX | Award | Jul 28, 2026 | $0 |
| Mangoceuticals, Inc. MGRX Current | Other | Dec 19, 2025 | Not reported |
| Mangoceuticals, Inc. MGRX | Gift | Sep 30, 2025 | $0 |
| Mangoceuticals, Inc. MGRX | Gift | Sep 30, 2025 | $0 |